Amy M. Duhig, PhD is Senior Director, New Product Planning, Value and Evidence Generation in U.S. Medical at Takeda. She has over 20 years of consulting, digital biotech, and biopharmaceutical company experience, both on scientific and commercial sides of the business. At Takeda, she is responsible for leading health economics and outcomes research for the U.S. pipeline. Prior to Takeda, she was Executive Director of Value Evidence at Cognoa, a digital diagnostic company for behavioral health, and was responsible for evidence generation and payer marketing. Regarding consulting, Amy was Vice President of Strategic Market Access and Intelligence at Xcenda. In this role, Amy was responsible for leading a team to deliver on U.S. market access services, payer agency, and primary research with payers, providers, and patients. Amy also led the Outcomes Research team at Xcenda. Prior to consulting, Amy held roles in health economics and outcomes research departments in mid- and large-size pharmaceutical companies, providing strategic and tactical support within a variety of therapeutic areas. Her experience includes work on U.S. and global products, small and large molecule assets, as well as specialty and orphan products. She has worked on products from Phase 1 to those late in their lifecycle.
Amy earned her PhD in Clinical Psychology from the University of South Florida. She completed her clinical internship at the University of Miami, Department of Pediatrics, Mailman Center for Child Development and a post-doctoral fellowship in the Department of Psychiatry at Yale University.
